AzTrials
AzTrials

Transcranial Magnetic StimilationPHAROSNCT07635615

Brain Oscillations and Neural States

A study testing Behavioral Treatment in people with Transcranial Magnetic Stimilation, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to investigate, through the use of electroencephalography (EEG), instantaneous brain states, namely rapid oscillations of the brain's electrical activity, and their relationship with behavior and brain functions. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Transcranial Magnetic Stimilation
What is being tested?
Behavioral Treatment
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteItaly
Study dates
1 Oct 2025to 26 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy adults

Who cannot join

  • Left-handedness (assessed through the Oldfield test)
  • Diagnosis of neurological or psychiatric disorders
  • Vision problems that prevent reading, not correctable with lenses
  • Diagnosis of substance dependence on drugs or alcohol
  • Presence of hearing aids/prostheses
  • Diagnosis of epilepsy or family history up to the second degree with it
Show all 19Show fewer
  • Episodes of febrile convulsions or recurrent fainting
  • Head trauma
  • Presence of surgical clips or metal implants in the head
  • Diagnosis of heart disease
  • Presence of a cardiac pacemaker or artificial heart valve
  • Presence of hearing aids/prostheses
  • Hearing problems or tinnitus
  • Vision problems not corrected with lenses (such as color blindness)
  • Taking tricyclic antidepressant medications
  • Taking neuroleptic medications
  • Diagnosis of headache or migraine
  • Taking more than 3 alcoholic units in the last 24 hours
  • Taking 2 or more cups of coffee or caffeine from other sources in the last 2 hours

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS San Camillo Hospital, Venice, Italy

    Venice-Lido

Other trials in Italy

About this study

Official title: Relationship Between Brain Oscillations and Neural States

The study aims to investigate, through the use of electroencephalography (EEG), instantaneous brain states, namely rapid oscillations of the brain's electrical activity, and their relationship with behavior and brain functions. The study will focus on three main objectives: (1) establishing a relationship between brain oscillations and behavior; (2) establishing a relationship between brain oscillations and brain functions, in terms of neural responsiveness; and (3) identifying the different phases of brain oscillations and investigating any related modulations of behavior and brain functions.

PHAROS will combine EEG with transcranial magnetic stimulation (TMS) to investigate and modulate brain states non-invasively.

Being tested
Behavioral Treatment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral TreatmentOther

    Imagining an abduction movement of the right index finger

  • Behavioral TreatmentOther

    Imagining the right index finger remaining still, which will serve as the control condition

Study groups in NCT07635615
Study groupRoleWhat they receive
Real motionExperimentalParticipants will be asked to perform a possible motor imagery task: imagining an abduction movement of the right index finger. Each session will consist of three blocks, counterbalanced across participants. During these blocks, single TMS pulses will be delivered at different phases of the EEG oscillation: positive peak, negative peak, and random phase, the latter serving as the control condition.
Receives: Other: Behavioral Treatment
No motionSham comparatorParticipants will be asked to perform a possible motor imagery task: imagining the right index finger remaining still, which will serve as the control condition. Each session will consist of three blocks, counterbalanced across participants. During these blocks, single TMS pulses will be delivered at different phases of the EEG oscillation: positive peak, negative peak, and random phase, the latter serving as the control condition.
Receives: Other: Behavioral Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor-evoked potential

    Motor-evoked potentials (MEPs) will be recorded from the right index-finger abductor muscle following single-pulse TMS delivered over the primary motor cortex. MEPs will be used as an index of corticospinal excitability. The main outcome measure will be the peak-to-peak MEP amplitude, calculated as the difference between the maximum and minimum EMG signal within the post-stimulation time window.

    Measured: Baseline

  2. Motor-evoked potential

    Motor-evoked potentials (MEPs) will be recorded from the right index-finger abductor muscle following single-pulse TMS delivered over the primary motor cortex. MEPs will be used as an index of corticospinal excitability. The main outcome measure will be the peak-to-peak MEP amplitude, calculated as the difference between the maximum and minimum EMG signal within the post-stimulation time window.

    Measured: Immediately after the intervention

  3. TMS-evoked potential

    TMS-evoked potentials (TEPs) will be recorded using EEG following single-pulse TMS. TEPs will be used as an index of cortical responsiveness to stimulation. The main outcome measures will be the amplitude and latency of the main TEP components within predefined post-stimulation time windows.

    Measured: Baseline

  4. TMS-evoked potential

    TMS-evoked potentials (TEPs) will be recorded using EEG following single-pulse TMS. TEPs will be used as an index of cortical responsiveness to stimulation. The main outcome measures will be the amplitude and latency of the main TEP components within predefined post-stimulation time windows.

    Measured: Immediately after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2026
  2. Study start1 Oct 2025
  3. Primary completion26 Feb 2026
  4. Study completion26 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07635615
Sponsor's protocol ID
2024.01
Acronym
PHAROS
Status last verified
Jun 2026
First submitted
3 Jun 2026
Last updated
9 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Treatment in people with Transcranial Magnetic Stimilation, run by IRCCS San Camillo, Venezia, Italy at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor-evoked potential (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in